Clinical reviewer: Dr. Sarah Boss, MD

COGNIFUL publishes this guide and is part of THE BALANCE GROUP. Its residence is in Mallorca, Spain, not the UK. The selected pathways are compared for their clinical roles and practical access, not presented as an independent luxury ranking or as equivalent treatment packages. [1] [2]

The NHS describes a GP or local drug treatment service as a starting point, with self-referral also possible. Treatment is based on the drugs involved and the person’s circumstances. This assessment remains useful if you intend to pay privately or travel: it can help identify medical needs, an appropriate care level, and which questions a prospective provider must answer. [3]

Prepare an accurate account of prescribed medicines, nonprescribed drugs, alcohol, recent use patterns, symptoms, and previous treatment. If a medication was prescribed for an ongoing condition, include the prescriber’s details and original reason. Do not make medication changes to simplify the story for admissions. Physical dependence and other patterns of problematic use need careful assessment rather than assumptions.

Urgent symptoms require urgent care. Breathing difficulty, seizures, severe chest pain, acute confusion, or an immediate psychiatric crisis should not wait for a private admission. A program offering later therapy may not be equipped to manage intoxication, severe withdrawal, or acute psychiatric needs. COGNIFUL may require another service to provide initial care before a residential stay. [4] [5] [6]

These are different choices about how care is delivered. Local treatment may allow the person to work directly with their everyday environment. Inpatient or overseas residential care creates time away and a later transition. Ask the assessor why the proposed setting fits current needs rather than assuming that a private residence is always the strongest option. [3]

Opioids and continuity of medication care

The CDC recommends medication treatment for opioid use disorder and advises against detoxification alone without medication because of increased return-to-use and overdose risks. Use that clinical evidence to ask about the actual pathway available to you. It does not establish that every residential program provides opioid medication or that the same arrangements apply in each country. [8]

If medication is already prescribed, discuss the proposed move with the current clinician. Who would prescribe during the stay, monitor treatment, and continue it in the UK afterward? A plan should not leave these responsibilities unresolved until discharge. Ask a prospective provider to state clearly when another service must remain involved.

Cocaine and other stimulants

For stimulant use disorder, ask about structured behavioral interventions. The ASAM/AAAP guideline identifies contingency management as a primary component alongside other psychosocial work. This is a defined way of reinforcing agreed treatment behaviors, not simply a supportive atmosphere. Ask whether the method is available and how it connects with cognitive behavioral or other treatment. [5]

Ask how mood, sleep, anxiety, and other psychiatric needs are reviewed. The stimulant guideline recognizes that these can need attention beyond the acute period. A provider should explain who evaluates symptoms and what would prompt a higher level of care. A short detox description does not explain the whole treatment program. [5]

Prescribed sedatives and the original clinical need

Benzodiazepine dependence can occur during prescribed use, and abrupt reduction or discontinuation can cause serious withdrawal. Any change needs a clinician-led plan. Ask how the provider distinguishes dependence from other problematic use and how it will address the condition the medicine was prescribed to treat. [4]

A planned residential duration may be different from the time required for a medical process. Ask how responsibilities continue if the stay ends before all prescribing decisions are complete. Avoid a proposal that treats a travel date or package end date as the reason to accelerate medication changes.

Cannabis-related problems

For cannabis, assess control, craving, unsuccessful efforts to reduce use, and effects on daily responsibilities or relationships. These are among the features the CDC describes for cannabis use disorder. Ask about the psychological methods proposed and whether outpatient care could meet the needs before assuming residence is required. [9] [10]

Ask the provider to explain how the different needs fit together. If substance use, prescribed medication, and mental health concerns are all relevant, identify the professional who leads decisions and how the other clinicians contribute. Separate appointments can be useful, but the patient should not have to act as the only link between conflicting recommendations.

Request a proposed week showing individual clinical sessions, medical reviews where relevant, shared activities, and other support. Clarify which parts are essential to the treatment and which are features of the residential experience. A busy timetable does not by itself show that the interventions match the substances or symptoms being treated.

Ask how goals are chosen and reviewed with you. The team should explain what progress would mean in the individual case, what information informs review, and how the plan changes when an approach is not helping. Attendance and completion are useful administrative facts, but they do not tell the whole story of treatment or the support needed afterward.

Clarify what happens outside scheduled sessions. Who can respond to a concern, how is clinical advice accessed, and what would trigger referral to another setting? Do not infer continuous medical coverage from a personal manager or a small residence. The provider’s actual arrangements need to match the needs identified during assessment.

Finally, ask which responsibilities you can realistically maintain during treatment. If work or caregiving arrangements require advance decisions, the clinical schedule should be clear enough to inform them. A program should help you understand the demands of participation rather than promise that every outside commitment can continue unchanged.

COGNIFUL is a residential program in Mallorca and part of THE BALANCE GROUP. Its named addiction pathways cover alcohol, cocaine, prescription drugs, and cannabis, with admission subject to assessment and availability. Those descriptions do not establish a specialist service for every drug or acute presentation. Ask whether any medical or psychiatric care needs to take place elsewhere before the residence is appropriate. [1] [6]

A maximum of four clients stay in the residence at any time, each in a private suite. Clinical and bodywork sessions are individual. The residence, chef, and personal manager are shared in both programs. Other holistic sessions, excursions, and activities are shared in Premier; every session and activity is individual in Premier Plus. Both tiers use this arrangement. The small capacity is a feature of the setting, not proof of a particular staffing ratio, session frequency, or clinical result. [2]

COGNIFUL Premier and Premier Plus both include assessment, a personal plan, and continuing-care planning. Plus adds individual therapeutic work, family and transition work, and three months of aftercare. Base-program follow-up is agreed individually. Typical stays are four to twelve weeks, reviewed for each person rather than fixed for every substance. [11] [12] View program fees

Request a clinical proposal that identifies the substances, methods, relevant professionals, and review process. COGNIFUL draws on THE BALANCE GROUP’s team according to the individual plan, so a team directory is not a guarantee that every professional participates. Similarly, a guideline recommendation does not establish that every modality or medication service is included. Ask directly about the services essential to your decision. [13] [14]

COGNIFUL is self-pay and does not directly bill insurers. Obtain a written total and clear inclusions, exclusions, and duration assumptions. For a UK resident, continuing care should identify the receiving clinician, appointments, and prescribing responsibilities where relevant. An aftercare description is not a promise of unrestricted cross-border clinical practice or a substitute for agreed local services. [11] [12] [15]

Ask an existing clinician or suitable local service whether it can receive the handoff. With consent, agree which records will be shared and who sends the discharge summary. COGNIFUL’s professional referral process can support coordination, but an actual individual agreement is needed. The patient should not be left to reconcile several unconnected recommendations. [15]

Make the first follow-up appointment part of discharge planning. Discuss how it will fit with work, family, and travel. If the program recommends ongoing medication or specialist monitoring, identify who will deliver it. A remote conversation with an overseas team may be useful when appropriate, but it should not be assumed to replace every UK clinical responsibility.

Ask the treating team to help translate treatment goals into ordinary routines. Which situations have been associated with use? What support is available when those situations return? What should happen if sleep, mood, or substance use changes? The plan should contain usable contacts and next steps, including reassessment when needed.

Family involvement should be chosen and bounded. Clarify what information relatives receive and what role they can realistically play. Practical support can be valuable without making a partner responsible for medication decisions or constant monitoring. The person receiving care should understand and participate in these agreements.

Compare full costs across the pathway: assessment, any separate stabilization, the proposed main treatment, and follow-up. Ask why one option recommends more time or a different intensity than another. A transparent explanation of clinical content is more useful than selecting the longest or most expensive stay as a proxy for quality.

Can I contact a UK drug service directly?

The NHS describes self-referral to local drug treatment services as well as speaking to a GP. Ask the local service about its assessment route and available treatment for the substances involved. [3]

Does COGNIFUL have a UK clinic?

The verified residence is in Mallorca, Spain. UK residents considering it need clinical acceptance, appropriate travel planning, and a receiving arrangement at home. [2] [16]

Can I stop prescribed medication before admission?

Do not make abrupt changes to fit a booking. Benzodiazepines in particular can cause serious withdrawal if stopped or reduced too quickly. Discuss the medication and any proposed change with the responsible clinician. [4]

How do I request a suitable COGNIFUL plan?

Provide accurate substance, medication, symptom, and treatment information. Ask for suitability, the proposed clinical work, written fees, and the UK transition plan before arranging travel. Include existing clinicians with consent when appropriate. [15] [11]

1. Addiction treatment at COGNIFUL — COGNIFUL
2. Life at COGNIFUL in Mallorca — COGNIFUL
3. Drug addiction: getting help — NHS
4. FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class — US Food and Drug Administration
5. ASAM/AAAP clinical practice guideline on the management of stimulant use disorder — American Society of Addiction Medicine and American Academy of Addiction Psychiatry
6. Clinical scope, suitability and care coordination — COGNIFUL
7. Priory Hospital Roehampton, London — Priory
8. Opioid use disorder: treating — Centers for Disease Control and Prevention
9. Understanding your risk for cannabis use disorder — Centers for Disease Control and Prevention
10. Psychosocial interventions for cannabis dependence — World Health Organization
11. COGNIFUL programs, fees and admissions — COGNIFUL
12. Reintegration and continuing care — COGNIFUL
13. Clinical team and care coordination — COGNIFUL
14. How residential treatment works at COGNIFUL — COGNIFUL
15. Professional referrals — COGNIFUL
16. Considering residential treatment in Mallorca: what to check before traveling — COGNIFUL

Source information checked October 18, 2026. Confirm current services, eligibility, fees, and availability directly with each provider.